investing.comOCT 73 min read$STZ

Earnings call transcript: Constellation Brands beats on Q2 2026 results, shares slip

Constellation Brands reported fiscal Q2 2027 earnings of $3.74 per share, beating estimates by $0.13, with revenue of $2.63 billion, also topping forecasts. The company reiterated its full-year EPS guidance of $11.20 to $11.90 and highlighted growth in its beer brands. Despite the beat, shares fell 0.96% in premarket trading, reflecting investor concerns over margins and spending. Management remains optimistic about the high end of its guidance range.

Original reporting

investing.com

Published Oct 7, 2026, 1:11 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 7, 2026, 1:46 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$STZ

Neutral

high confidence

Mentioned

$STZ

Relevance

8/10

AlphAI data visualization · based on investing.com

Decision brief

The 30-second read

$STZNeutralMed

Why it matters

Earnings beat was modest; investors focused on margin pressure and elevated marketing spend, causing a pre‑market decline.

Market read

The earnings release provides fresh guidance and operational updates that may influence short‑term trading in STZ and peers.

What to watch

The $530 M share repurchase and $2.5 B authorization provide long‑term support that may be under‑appreciated.

Relevance 8/10Novelty 8/10Timing: premarket today

Background

Constellation Brands (STZ) is a leading beverage alcohol company with brands like Corona, Modelo and Pacifico.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$STZNeutralHigh confidence

Context

Constellation Brands reported Q2 2027 earnings beating estimates but shares slipped 0.96% pre‑market, indicating mixed market reaction.

Expected impact

likely modest pressure as investors weigh higher marketing spend against growth; stock may stay flat or dip slightly.

Evidence & confidence

The beat was modest and guidance unchanged, while investors highlighted margin headwinds, suggesting limited upside.

Market effects

Sector

Beverage alcohol sector may see renewed focus on margin management and capital allocation.

Regional

U.S. consumer discretionary stocks could experience slight pullback as investors reassess spending trends.

Global

Limited; the news is primarily U.S. focused with modest ripple to global alcohol producers.

Counterpoint

What could challenge this read

Despite the share dip, the beat and strong cash flow could support a short‑term bounce if margins improve.

Key entities

Executive
Nick Fink
CEO who highlighted growth and margin outlook.
Facility
Veracruz
New plant expected to add $75 M depreciation in FY2028.

Read at source ← All news

NOV 2

$STZMed

Jefferies raises Constellation Brands stock price target on beer margin outlook

Jefferies raised its price target for Constellation Brands (STZ) to $142 from $135, maintaining a Hold rating. The firm cited improved beer margin outlook and recent share gains. STZ's P/E ratio is 12.09, with a PEG ratio of 0.19. The company reported Q2 net sales of $2.63B, up 6% YoY, with EPS of $3.74. Other analysts have mixed outlooks.

investing.com2 min

OCT 31

$STZMed

Judge keeps distribution deal in place after Coors warns of nine-figure losses

A Denver judge blocked Constellation Brands from canceling its distribution deal with Coors Distributing Company (CDC), a subsidiary of Molson Coors, citing potential $100M+ losses and reputational harm. CDC claims the deal is worth over nine figures. Constellation disputes CDC's claims. A hearing on CDC's lawsuit against Mark Anthony Brands is scheduled.

denverpost.com2 min

OCT 12

$STZMedAI 8/10

Constellation Brands Agrees to Buy SpikedAde for Up to $353 Million

Constellation Brands (STZ) agreed to buy SpikedAde for up to $353M, entering the 'hard hydration' alcohol segment. The deal follows Q2 results showing beer sales growth but softer retail demand. CEO Nick Fink aims to diversify, though past acquisitions have underperformed. Analysts note the deal's manageable size but caution about the category's long-term potential.

vinetur.com7 min

OCT 12

$STZMedAI 8/10

Constellation Brands reports a 26% drop in first-half wine and spirits sales

Constellation Brands reported a 26% drop in wine and spirits net sales to $308.6M for the first half of its fiscal year, largely due to 2025 divestitures. Organic sales in the segment grew 12%. Group net sales rose 1% to $5.066B, with beer sales up 4% to $4.757B. Net income increased 24% to $1.220B. The company maintained a cautious outlook for the rest of the year.

vinetur.com2 min

OCT 11

$STZHighAI 8/10

Constellation Brands: Q2 Revenue Rises 6% To $2.63 Billion As Beer And Wine And Spirits Sales Grow

Constellation Brands reported Q2 fiscal 2027 net sales of $2.63B, up 6% YoY. Beer sales rose 5% to $2.47B, while Wine and Spirits sales increased 17% to $159.4M. Operating income fell 8% to $805M, but EPS rose 25% to $3.32. The company acquired SpikedAde for $75M, with up to $278M in contingent payments. Constellation updated its fiscal 2027 EPS guidance to $11.85-$12.55 and declared a $1.03 quarterly dividend.

pulse2.com3 min

OCT 9

$LWLow

Earnings market review: beats fall short as guidance and costs drive reactions

Lamb Weston (LW) and Constellation Brands (STZ) reported earnings beats but faced mixed reactions due to guidance and cost pressures. PepsiCo (PEP) and Delta Air Lines (DAL) also reported, with DAL missing EPS estimates. Analysts note that estimate revisions, not just beats, are driving market reactions. The macro backdrop includes high yields and expensive oil, impacting earnings expectations.

uk.investing.com3 min